Ping An Biomedical hires Edston as new auditor

Ping An Biomedical Co., Ltd. reported a change in its independent auditors.

Rhea-AI Filing Summary

Ping An Biomedical Co., Ltd. reported a change in its independent auditors. On August 5, 2026, the board resolved not to reappoint WWC, P.C. as independent accountants, ending a relationship that began with the year ended September 30, 2020. WWC’s reports for the fiscal years ended September 30, 2024 and 2025 contained no adverse opinions or qualifications, and the company reports no disagreements or reportable events during WWC’s engagement.

The board approved the appointment of Edston Global PAC as the new independent registered public accounting firm, effective August 6, 2026. The company states it did not consult Edston on accounting principles, audit opinions, or any disagreements before this appointment. WWC’s confirming letter to the SEC, dated August 7, 2026, is included as an exhibit.

Key Figures

Board decision date on former auditor: August 5, 2026 New auditor effective date: August 6, 2026 WWC tenure start period: year ended September 30, 2020 +2 more

5 metrics

Board decision date on former auditor August 5, 2026 Board resolved not to reappoint WWC, P.C. as independent accountants, effective that date.

New auditor effective date August 6, 2026 Edston Global PAC engaged as independent registered public accounting firm from this date.

WWC tenure start period year ended September 30, 2020 WWC, P.C. has rendered reports on consolidated financial statements since this reporting year.

Fiscal years with no adverse opinion September 30, 2024 and 2025 WWC provided no adverse opinions or qualifications on these fiscal year financial statements.

WWC letter date August 7, 2026 WWC’s letter to the SEC is dated this day and attached as Exhibit 16.1.

Key Terms

independent registered public accounting firm, reportable events, Item 16F(a)(1)(v) of Form 20-F, foreign private issuer, +1 more

5 terms

independent registered public accounting firm regulatory

"We have engaged Edston Global PAC as our independent registered public accounting firm..."

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

reportable events regulatory

"None of the reportable events described under Item 16F(a)(1)(v) of Form 20-F occurred..."

Reportable events are significant incidents or changes a company is legally required to disclose to regulators and the public, such as major safety problems, legal actions, financial irregularities, or management changes. They matter to investors because these events can alter a company’s risk profile or future performance, much like a dashboard warning light signals a problem that could affect a car’s safety or reliability. Timely disclosure helps investors make informed decisions and maintain market fairness.

Item 16F(a)(1)(v) of Form 20-F regulatory

"None of the reportable events described under Item 16F(a)(1)(v) of Form 20-F occurred..."

foreign private issuer regulatory

"Form 6-K report of foreign private issuer pursuant to Rule 13a-16..."

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Form 20-F regulatory

"whether the registrant files or will file annual reports under cover Form 20-F..."

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What auditor change did Ping An Biomedical (PASW) report?

Ping An Biomedical reported that its board decided on August 5, 2026 not to reappoint WWC, P.C. as independent accountants and instead engaged Edston Global PAC as its new independent registered public accounting firm, effective August 6, 2026.

Were there any disagreements with WWC, P.C. for Ping An Biomedical (PASW)?

The company states that during the fiscal years ended September 30, 2024 and 2025, and through this filing date, WWC had no disagreements with Ping An Biomedical on accounting principles, financial statement disclosure, or audit scope, and no reportable events occurred under Item 16F(a)(1)(v) of Form 20-F.

How long had WWC, P.C. served as Ping An Biomedical’s (PASW) auditor?

WWC, P.C. had rendered reports on Ping An Biomedical’s consolidated financial statements since the year ended September 30, 2020. The change therefore ends a multi-year auditor relationship covering several reporting periods, including the fiscal years ended September 30, 2024 and 2025.

When did Edston Global PAC become Ping An Biomedical’s (PASW) new auditor?

Edston Global PAC was engaged as Ping An Biomedical’s independent registered public accounting firm effective August 6, 2026. The company notes that this engagement followed board approval and that it had not previously consulted Edston on accounting principles or potential audit opinions.

Did Ping An Biomedical (PASW) consult Edston before appointing it auditor?

Ping An Biomedical states it had not consulted Edston during the two most recent fiscal years and up to this report on applying accounting principles, expected audit opinions, or any disagreement matters that would influence its accounting or financial reporting decisions.

What document from WWC, P.C. did Ping An Biomedical (PASW) include with this filing?

The company included as Exhibit 16.1 a letter from WWC, P.C. dated August 7, 2026 and addressed to the SEC. WWC was provided a copy of the report and its letter is incorporated by reference into the submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:31 PM Accepted by SEC EDGAR 08/07/2026 - 04:30 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2026

Commission File Number: 001-42155 

Ping An Biomedical Co., Ltd.

(Registrant’s Name)

22/F, China United Plaza, 1002-1008, Tai Nan West Street,

Cheung Sha Wan, Kowloon, Hong Kong 

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

When used in this Form 6-K, unless otherwise indicated, the terms “the Company,” “ Ping An Biomedical Co., Ltd. ,” “we,” “us” and “our” refer to  Ping An Biomedical Co., Ltd. and its subsidiaries.

Changes in Registrant’s Certifying Accountant

Previous Independent Registered Public Accounting Firm

On August 5, 2026, our board of directors resolved not to reappoint WWC, P.C. (“WWC”) as our independent accountants. We informed WWC of this determination on August 5, 2026, which was effective August 5, 2026. The Company would like to extend sincere appreciation to WWC for its dedication throughout the years.

WWC, P.C. has rendered reports on our consolidated financial statements since the year ended September 30, 2020. During the fiscal years ended September 30, 2024 and 2025 through the date of this form 6-K, WWC has neither provided any adverse opinion or qualifications on our consolidated financial statements nor had a disagreement with the Company since their engagement on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements that, if not resolved to WWC’s satisfaction, would have caused WWC to make reference to the subject matter of the disagreement in connection with the audit of the Company’s consolidated financial statements.

None of the reportable events described under Item 16F(a)(1)(v) of Form 20-F occurred within period of the engagement of WWC.

We have provided WWC with a copy of this report prior to its filing with the Securities and Exchange Commission (the “SEC”). WWC has provided a letter to us, dated August 7, 2026 and addressed to the SEC, which is attached hereto as Exhibit 16.1 and is hereby incorporated herein by reference.

New independent registered public accounting firm

We have engaged Edston Global PAC (“Edston”) as our independent registered public accounting firm, effective August 6, 2026. The decision to engage Edston as our independent registered public accounting firm was approved by our board of directors.

During the two most recent fiscal years and through the date of this report, we have not consulted with Edston regarding any of the following:

1.	the application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements;
2.	the type of audit opinion that might be rendered on the Company’s financial statements by Edston, in either case where written or oral advice provided by Edston would be an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issues; or
3.	any matter that was either the subject of a disagreement (as described under Item 16F(a)(1)(v) of Form 20-F)

Financial Statements and Exhibits.

Exhibit No.		Description
16.1		Letter of WWC, P.C. dated August 7, 2026

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PING AN BIOMEDICAL CO., LTD.
Date: August 7, 2026	By:	/s/ Pijun Liu
	Name:	Pijun Liu
	Title:	Chairperson of the Board of Directors

2

Filing Exhibits & Attachments

1 document

Other Documents

• EX-16.1 LETTER OF WWC, P.C. DATED AUGUST 7, 2026 3.4 KB